13F Holdings
中文EN

SGRX SANGRIX INC. Annual reports only

Finance Services · Nasdaq · SEC CIK 1735556 · Fiscal year ends 06/30

Financial factors as of 2025-06-30 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-98.6%
TTM net income YoY75.0%
TTM EPS YoY91.5%
Revenue 3-yr CAGR-41.0%
Net income 3-yr CAGR—

Margins

Gross margin100.0%
Operating margin-7,574.9%
Net margin-11,108.2%
FCF margin—
EBITDA margin-7,574.9%

Returns

ROE-157.7%
ROA-85.8%
ROIC (approx.)-115.3%
Asset turnover0.01x

Leverage & solvency

Liabilities / assets10.5%
Debt / equity0.00x
Current ratio9.50x
Interest coverage-4.50x

Cash quality & payout

Operating cash flow / net income0.52x
Accruals ratio-41.0%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY2026*2026-06-30FY2025*2025-06-30FY20242024-06-30FY20232023-06-30FY20222022-06-30
Income statement
Revenue—$39,495$2.89M$6.26M$192,351
Cost of revenue——$3.83M$10.83M$10.83M
Gross profit—$39,495-$945,202-$4.57M-$4.57M
SG&A expense$2.75M$3.08M$3.82M$2.91M$2.91M
Operating income-$14.28M-$2.99M-$14.84M-$28.30M-$28.30M
Interest expense—$665,194$595,685$36,380$227,376
Pretax income-$14.29M-$4.37M-$18.28M-$28.22M-$28.22M
Net income-$14.29M-$4.39M-$17.53M-$28.22M$3.24M
EBITDA—-$2.99M-$13.93M-$22.94M—
EPS (basic)-70.43-84.84-1,003.41—-8.61
EPS (diluted)-70.43-84.84-1,003.41—-8.61
Weighted avg. shares (diluted)339,69977,01617,4723.28M3.28M
Banking
Loans, net$13.42M$1.89M———
Balance sheet
Cash & equivalents$1.57M$55,639$1.41M$16,274$17,805
Receivables——$117,000$0$0
Current assets$10.17M$3.54M$6.68M$3.57M$23.93M
PP&E, net———$7.37M$8.03M
Total assets$21.16M$3.54M$6.68M$13.34M$34.95M
Current liabilities$1.46M$372,083$2.49M$2.59M$299,968
Total liabilities$12.08M$372,083$5.78M$3.07M$299,968
Shareholders' equity$5.62M$3.90M$1.66M$10.26M$34.65M
Shares outstanding—970,1857.76M3.38M3.06M
Cash flow statement
Operating cash flow-$2.92M-$2.29M-$7.93M-$6.76M-$14.24M
Capital expenditure———$115,033$8.30M
Free cash flow———-$6.88M-$22.54M
Investing cash flow-$200,000$1.55M$1.02M$4.27M-$11.31M
Financing cash flow$4.64M-$608,712$8.30M$2.49M$25.94M
Depreciation & amortization—$0$900,938$5.36M—
Stock-based compensation——$73,230$67,271$67,271

Free plan shows the latest 5 periods; Pro shows all 10 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.